Business Description
GSK PLC
ISIN : GB00BN7SWP63
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.18 | |||||
Debt-to-EBITDA | 2.1 | |||||
Interest Coverage | 9.24 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.9 | |||||
3-Year EBITDA Growth Rate | 3.3 | |||||
3-Year EPS without NRI Growth Rate | 15 | |||||
3-Year FCF Growth Rate | -12.6 | |||||
3-Year Book Growth Rate | -3.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 12.92 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.7 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
12-1 Month Momentum % | 17.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 233.17 | |||||
Days Sales Outstanding | 81.98 | |||||
Days Payable | 516.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.69 | |||||
Dividend Payout Ratio | 0.54 | |||||
3-Year Dividend Growth Rate | -17.7 | |||||
Forward Dividend Yield % | 4.15 | |||||
5-Year Yield-on-Cost % | 2.17 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 9.14 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.07 | |||||
Operating Margin % | 19.9 | |||||
Net Margin % | 12.83 | |||||
FCF Margin % | 16.43 | |||||
ROE % | 29.93 | |||||
ROA % | 6.81 | |||||
ROIC % | 11.06 | |||||
3-Year ROIIC % | -9.48 | |||||
ROC (Joel Greenblatt) % | 58.83 | |||||
ROCE % | 14.98 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.78 | |||||
Forward PE Ratio | 8.16 | |||||
PE Ratio without NRI | 13.32 | |||||
Shiller PE Ratio | 9.37 | |||||
Price-to-Owner-Earnings | 8.83 | |||||
PEG Ratio | 13.32 | |||||
PS Ratio | 1.9 | |||||
PB Ratio | 4.11 | |||||
Price-to-Free-Cash-Flow | 11.47 | |||||
Price-to-Operating-Cash-Flow | 7.97 | |||||
EV-to-EBIT | 12.82 | |||||
EV-to-Forward-EBIT | 7.64 | |||||
EV-to-EBITDA | 9.03 | |||||
EV-to-Forward-EBITDA | 6.37 | |||||
EV-to-Revenue | 2.32 | |||||
EV-to-Forward-Revenue | 2.18 | |||||
EV-to-FCF | 14.06 | |||||
Price-to-Projected-FCF | 0.93 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Earnings Yield (Greenblatt) % | 7.8 | |||||
FCF Yield % | 8.79 | |||||
Forward Rate of Return (Yacktman) % | 4.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
GSK PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 689,128.514 | ||
EPS (TTM) (MXN) | 21.484 | ||
Beta | -0.25 | ||
Volatility % | 18.07 | ||
14-Day RSI | 100 | ||
14-Day ATR (MXN) | 0.360522 | ||
20-Day SMA (MXN) | 363.1745 | ||
12-1 Month Momentum % | 17.14 | ||
52-Week Range (MXN) | 305.05 - 367.94 | ||
Shares Outstanding (Mil) | 4,078.99 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GSK PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GSK PLC Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
GSK PLC Frequently Asked Questions
What is GSK PLC(MEX:GSK1)'s stock price today?
When is next earnings date of GSK PLC(MEX:GSK1)?
Does GSK PLC(MEX:GSK1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |